Course Exam
301907 VO Development of novel cancer immunotherapies (2023W)
from target identification through target validation to clinical trials
Labels
ON-SITE
WHEN?
Monday
11.12.2023
15:00 - 17:00
BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Su 01.10.2023 09:00 to Su 10.12.2023 09:00
- Deregistration possible until Su 10.12.2023 09:00
Examiners
Information
Examination topics
The lecture concludes with a written exam
the exam consists of 5 multiple choice and 5 open questions
the exam consists of 5 multiple choice and 5 open questions
Assessment and permitted materials
written exam
Minimum requirements and assessment criteria
100-87%: Sehr Gut ( I ); 87,99-75%: Gut (2); 74,99-62%: Befriedigend (3); 6 I ,99-50%: Genügend (4); < 50%: Nicht Genügend (5)
Last modified: Tu 24.10.2023 08:28